Scripps looks outward

The Scripps Research Institute has borrowed a page from the VC playbook and formed a separate corporation called Scripps Advance LLC that will house assets and IP related to discrete early stage research projects. The goal is to attract pharma investment in translational assets. Johnson & Johnson's California Innovation Center is on board as Scripps Advance's first partner.

Two years ago Scripps decided to move away from the institute-wide option agreements it previously maintained with pharma companies including Pfizer Inc. and Novartis AG.¹...